Plasmatic carbonic anhydrase IX as a diagnostic marker for clear cell renal cell carcinoma

Carbonic anhydrase (CA, EC 4.2.1.1) IX is regarded as a tumour hypoxia marker and CA inhibitors have been proposed as a new class of antitumor agents, with one such agent in Phase II clinical trials. The expression of some CAs, in particular the isoforms CA IX and CA XII, has been correlated with tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucarini, Laura, Magnelli, Lucia, Schiavone, Nicola, Crisci, Alfonso, Innocenti, Alessio, Puccetti, Luca, Cianchi, Fabio, Peri, Sara, Supuran, Claudiu T., Papucci, Laura, Masini, Emanuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011953/
https://www.ncbi.nlm.nih.gov/pubmed/29251173
http://dx.doi.org/10.1080/14756366.2017.1411350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011953/
https://www.ncbi.nlm.nih.gov/pubmed/29251173
http://dx.doi.org/10.1080/14756366.2017.1411350

Ejemplares similares